Protalix BioTherapeutics PLX
NYSE PLX
$2.57 -0.07 (-2.65%)
As of: Oct 21, 2026 · 3:59 PM EDT

Protalix BioTherapeutics (PLX) EV to CFO (2012 - 2026)

Updated

Protalix BioTherapeutics' EV to CFO was 14.82 in Q2 2026, up 80.7% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) EV to CFO (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Protalix BioTherapeutics' EV to CFO was 3.66 through Jun 30, 2026; for FY2024, it was 12.42.

  • The Q2 2026 figure marks the highest quarterly EV to CFO since Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Protalix BioTherapeutics 207.16 Mn 55.78 Mn 12.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.82
Mar 31, 2026 8.20
Dec 31, 2024 12.42
Sep 30, 2024 5.76
Mar 31, 2024 7.48
Sep 30, 2018 4.76
Dec 31, 2012 682.17
API Access

Protalix BioTherapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PLX&period=max&api_key=YOUR_API_KEY